Table 1.
Number | Time | |
---|---|---|
Age at RT | ||
Diagnosis | 1.68 years (0.01–3.02 years) | |
Radiation Therapy | 2.12 years (0.89–3.10 years) | |
Last Follow-up | 20.81 years (7.46–26.84 years) | |
Sex | ||
M | 55 | |
F | 46 | |
Race/Ethnicity | ||
Asian | 4 | |
Black | 9 | |
Hispanic | 4 | |
Other | 4 | |
White | 80 | |
Extent of Resection | ||
Gross-total Resection | 83 | |
Near-total Resection | 7 | |
Sub-total Resection | 11 | |
Clinical Target Volume Margin | ||
0.5cm | 22 | |
1.0cm | 79 | |
Total Dose | ||
54.0 Gy | 28 | |
59.4 Gy | 73 | |
Tumor Location | ||
Infratentorial | 90 | |
Supratentorial | 11 | |
Grade | ||
Classic | 30 | |
Anaplastic | 71 | |
Shunt | ||
None | 49 | |
Yes | 52 | |
Cause of Death | ||
Tumor Progression | 24 | |
High-grade Glioma | 6 | |
Necrosis | 2 | |
Shunt Failure | 1 | |
Anaphylaxis | 1 | |
Pattern of Failure | ||
Local | 17 | 2.02 years (0.86–9.46 years) |
Distant | 11 | 1.70 years (0.39–4.48 years) |
Local and Distant | 6 | 0.89 years (0.63–2.90 years) |
Secondary Tumor | ||
Benign Thyroid Nodule | 5 | 14.4 years (4.00–16.19 years) † |
Meningiomatosis | 1 | 4.92 years |
Cholesteatoma | 1 | 13.01 years |
Low-grade glioma | 1 | 2.80 years |
High-grade Glioma | 6 | 9.79 years (4.05–14.53 years) ‡ |
Meningioma | 7 | 14.25 years (6.19–18.39 years) |
Papillary Thyroid Cancer | 3 | 9.16 years (6.84–11.32 years) |
Vestibular Schwannoma | 1 | 11.14 years |
Two patients who developed thyroid nodules in addition to meningioma are included.
Two re-irradiated patients who developed high-grade glioma 8.39 and 14.53 years after their initial treatment with radiation therapy are included.